RT Journal Article
SR Electronic
T1 Genetic variation affects morphological retinal phenotypes extracted from UK Biobank Optical Coherence Tomography images
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.20.20157180
DO 10.1101/2020.07.20.20157180
A1 Hannah Currant
A1 Pirro Hysi
A1 Tomas W Fitzgerald
A1 Puya Gharahkhani
A1 Pieter W M Bonnemaijer
A1 UK Biobank Eye and Vision Consortium
A1 International Glaucoma Genetics Consortium
A1 Denize Atan
A1 Tin Aung
A1 Jason Charng
A1 Hélène Choquet
A1 Jamie Craig
A1 Alex W Hewitt
A1 Peng T Khaw
A1 Caroline C W Klaver
A1 Michiaki Kubo
A1 Jue-Sheng Ong
A1 Louis R Pasquale
A1 Charles A Reisman
A1 Mark J Simcoe
A1 Alberta A H J Thiadens
A1 Cornelia M van Duijn
A1 Seyhan Yazar
A1 Eric Jorgenson
A1 Stuart MacGregor
A1 Chris J Hammond
A1 David A Mackey
A1 Janey L Wiggs
A1 Paul J Foster
A1 Praveen J Patel
A1 Ewan Birney
A1 Anthony P Khawaja
YR 2020
UL http://medrxiv.org/content/early/2020/07/26/2020.07.20.20157180.abstract
AB Optical Coherence Tomography (OCT) enables non-invasive imaging of the retina and is often used to diagnose and manage multiple ophthalmic diseases including glaucoma. We present the first large-scale quantitative genome-wide association study of inner retinal morphology using phenotypes derived from OCT images of 31,434 UK Biobank participants. We identify 46 loci associated with thickness of the retinal nerve fibre layer or ganglion cell inner plexiform layer. Only one of these loci has previously been associated with glaucoma, and Mendelian randomisation confirms that inner retinal thickness, despite being a valid biomarker for the disease, is not on the same genetic causal pathway as glaucoma. Image analysis methods were used to extract overall retinal thickness at the fovea, representative of hypoplasia, with which three out of the 46 SNPs were associated. These SNPs have been previously linked with pigmentation, confirmed by their association with hair colour in the UK Biobank dataset. We additionally associate these three loci with visual acuity. In contrast to the already known Mendelian causes of severe foveal hypoplasia, our results suggest a previously unknown spectrum of foveal hypoplasia in the population, in part genetically determined, that has consequences on visual function.Competing Interest StatementLRP is consultant for Verily, Eyenovia, Bausch+Lomb, and Nicox. JW is consultant for Allergan, Editas, Maze, Regenxbio and has a sponsored research grant from Aerpio.Funding StatementHC and EB are funded by EMBL. APK is supported by a Moorfields Eye Charity Career Development Fellowship. The Rotterdam Study is funded by Erasmus MC and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The authors are extremely grateful for the selfless participation of individuals in all cohorts used in this study (the UK BioBank, The Rotterdam Study and the Raine Study), and the staff managing these cohorts. LP is funded by NIH EY015473. JW is funded by NIH/NEI P30 EY014104 and R01 EY022305. AH is supported by an Australian National Health and Medical Research Council Practitioner Fellowship. EJ and HC are supported by National Eye Institute (NEI) grant R01 EY027004 and by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01 DK116738.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was conducted with the approval of the North-West Research Ethics Committee (ref 06/MRE08/65), in accordance with the principles of the Declaration of Helsinki, and all participants gave written informed consent. This research has been conducted using the UK Biobank Resource under Application Number 2112.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe genetic and phenotypic UK Biobank data are available upon application to the UK Biobank.